pazopanib hydrochloride

Poland

Drugs containing this active substance

  • PAZOPANIB PHARMASCIENCE

    The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (including metastatic) and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 200 mg

    ATC: L01XE03

    Manufacturer: PharOS Mt Ltd

  • PAZOPANIB PHARMASCIENCE

    This medicine is used in adults to treat advanced renal cell carcinoma (including metastatic) and in the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 400 mg

    ATC: L01XE03

    Manufacturer: PharOS Mt Ltd

  • PAZOPANIB REDDY

    The medicine is used in adults for the treatment of advanced renal cell carcinoma (with metastases to other organs) and in certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride No input provided

    ATC: L01EX03

    Manufacturer: Betapharm Arzneimittel GmbH

  • PAZOPANIB REDDY

    The medicine is used in adults for the treatment of advanced or metastatic renal cell carcinoma and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride No input provided

    ATC: L01EX03

    Manufacturer: Betapharm Arzneimittel GmbH

  • PAZOPANIB STADA

    The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (with metastases to other organs) and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 216.7 mg

    ATC: L01EX03

    Manufacturer: PharOS Mt Ltd Remedica Ltd STADA Arzneimittel AG

  • PAZOPANIB STADA

    The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (including metastatic) and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 433.4 mg

    ATC: L01EX03

    Manufacturer: PharOS Mt Ltd Remedica Ltd STADA Arzneimittel AG

  • PAZOPANIB TZF

    The medicine is used in adults for the treatment of advanced or metastatic renal cell carcinoma and in certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 216.7 mg

    ATC: L01EX03

    Manufacturer: Bluepharma Industria Farmaceutica S.A.

  • PAZOPANIB TZF

    The medicinal product is used in adults for the treatment of advanced renal cell carcinoma (with metastases to other organs) and in certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 433.4 mg

    ATC: L01EX03

    Manufacturer: Bluepharma Industria Farmaceutica S.A.

  • PAZOPANIB ZENTIVA

    The medicine is used in adults for the treatment of advanced renal cell carcinoma and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 200 mg

    ATC: L01EX03

    Manufacturer: PharOS Mt Ltd

  • PAZOPANIB ZENTIVA

    The medicine is used in adults for the treatment of advanced renal cell carcinoma (which has spread to other organs) and for the treatment of certain types of soft tissue sarcoma.

    Form: tablets, film-coated

    Active substance Dosage
    pazopanib hydrochloride 400 mg

    ATC: L01EX03

    Manufacturer: PharOS Mt Ltd